Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.
Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D, Padbury R, Moore MJ, Gallinger S, Mariette C, Wente MN, Izbicki JR, Friess H, Lerch MM, Dervenis C, Oláh A, Butturini G, Doi R, Lind PA, Smith D, Valle JW, Palmer DH, Buckels JA, Thompson J, McKay CJ, Rawcliffe CL, Büchler MW; European Study Group for Pancreatic Cancer. Neoptolemos JP, et al. Among authors: friess h. JAMA. 2010 Sep 8;304(10):1073-81. doi: 10.1001/jama.2010.1275. JAMA. 2010. PMID: 20823433 Clinical Trial.
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.
Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ, Büchler MW; European Study Group for Pancreatic Cancer. Neoptolemos JP, et al. Among authors: friess h. N Engl J Med. 2004 Mar 18;350(12):1200-10. doi: 10.1056/NEJMoa032295. N Engl J Med. 2004. PMID: 15028824 Free article. Clinical Trial.
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.
Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P, Dervenis C, Fernandez-Cruz L, Lacaine F, Pap A, Spooner D, Kerr DJ, Friess H, Büchler MW; European Study Group for Pancreatic Cancer. Neoptolemos JP, et al. Among authors: friess h. Lancet. 2001 Nov 10;358(9293):1576-85. doi: 10.1016/s0140-6736(01)06651-x. Lancet. 2001. PMID: 11716884 Clinical Trial.
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.
Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, Bassi C, Dervenis C, Fernandez-Cruz L, Lacaine F, Buckels J, Deakin M, Adab FA, Sutton R, Imrie C, Ihse I, Tihanyi T, Olah A, Pedrazzoli S, Spooner D, Kerr DJ, Friess H, Büchler MW; European Study Group for Pancreatic Cancer. Neoptolemos JP, et al. Among authors: friess h. Ann Surg. 2001 Dec;234(6):758-68. doi: 10.1097/00000658-200112000-00007. Ann Surg. 2001. PMID: 11729382 Free PMC article. Clinical Trial.
[Adjuvant and additive therapy for cancer of the pancreas].
Neoptolemos JP, Raraty MG, Ghaneh P, Hickey H, Stocken DD, Dunn JA, Friess H, Büchler MW. Neoptolemos JP, et al. Among authors: friess h. Chirurg. 2003 Mar;74(3):191-201. doi: 10.1007/s00104-003-0614-x. Chirurg. 2003. PMID: 12647075 Review. German.
Adjuvant therapy in pancreatic cancer: historical and current perspectives.
Neoptolemos JP, Cunningham D, Friess H, Bassi C, Stocken DD, Tait DM, Dunn JA, Dervenis C, Lacaine F, Hickey H, Raraty MG, Ghaneh P, Büchler MW. Neoptolemos JP, et al. Among authors: friess h. Ann Oncol. 2003 May;14(5):675-92. doi: 10.1093/annonc/mdg207. Ann Oncol. 2003. PMID: 12702520 Free article. Review.
Pancreatic cancer: from bench to 5-year survival.
Kleeff J, Michalski C, Friess H, Büchler MW. Kleeff J, et al. Among authors: friess h. Pancreas. 2006 Aug;33(2):111-8. doi: 10.1097/01.mpa.0000229010.62538.f2. Pancreas. 2006. PMID: 16868475 Review.
Approaches to localized pancreatic cancer.
Loos M, Kleeff J, Friess H, Büchler MW. Loos M, et al. Among authors: friess h. Curr Oncol Rep. 2008 May;10(3):212-9. doi: 10.1007/s11912-008-0033-8. Curr Oncol Rep. 2008. PMID: 18765151 Review.
Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer-Subset analysis of the ESPAC-1 data.
Carter R, Stocken DD, Ghaneh P, Bramhall SR, Olah A, Kelemen D, Bassi C, Friess H, Dervenis C, Spry N, Büchler MW, Neoptolemos JP; European Study Group for Pancreatic Cancer (ESPAC). Carter R, et al. Among authors: friess h. Int J Cancer. 2009 Jun 15;124(12):2960-5. doi: 10.1002/ijc.24270. Int J Cancer. 2009. PMID: 19330830 Free article. Clinical Trial.
Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1).
Neoptolemos JP, Baker P, Beger H, Link K, Pederzoli P, Bassi C, Dervenis C, Friess H, Büchler M. Neoptolemos JP, et al. Among authors: friess h. Int J Pancreatol. 1997 Apr;21(2):97-104. doi: 10.1007/BF02822380. Int J Pancreatol. 1997. PMID: 9209950 Clinical Trial.
1,214 results